Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis

Affiliations

• ¹ Department of Neurology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany [email protected] [email protected].
• ² Department of Neurology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
• ³ Department of Haematology, Oncology, and Cell Therapy, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
• ⁴ Health Campus Immunology, Infectiology, and Inflammation, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
• ⁵ Department of Neurology, Ruhr University Bochum, Bochum, Germany.
• ⁶ Kyverna Therapeutics, Emeryville, California, USA.
• ⁷ Experimental Rheumatology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
• ⁸ Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-University Erlangen, Erlangen, Germany.
• ⁹ Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen, Erlangen, Germany.
• ¹⁰ Department of Haematology, Oncology, and Cell Therapy, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany [email protected] [email protected].